Scholar Rock Holding (SRRK) Restructuring Costs (2024 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Restructuring Costs of $16.1 million for Q1 2026, up 80.41% year-over-year from $8.9 million in Q1 2025, and up 26.48% quarter-over-quarter from $12.8 million in Q4 2025.
Scholar Rock Holding (SRRK) Restructuring Costs (2024 - 2026) Analysis & Trends
Scholar Rock Holding's Restructuring Costs history runs 3 years deep, the most recent figure standing at $16.1 million for Q1 2026.
- In Q1 2026, Restructuring Costs rose 80.41% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $63.3 million (up 140.35% YoY), while the FY2025 annual figure was $56.1 million, up 150.55% from the prior year.
- Restructuring Costs for Q1 2026 stood at $16.1 million, up from $12.8 million in the prior quarter.
- The five-year high for Restructuring Costs was $19.4 million in Q3 2025, with the low at $5.0 million in Q1 2024.
- The 3-year median for Restructuring Costs is $8.9 million (2025), against an average of $10.5 million.
- Peak annual rise in Restructuring Costs reached 281.56% in 2025, while the deepest fall reached 78.8% in 2025.
- Scholar Rock Holding's Restructuring Costs stood at $6.2 million in 2024, then jumped by 106.96% to $12.8 million in 2025, then climbed by 26.48% to $16.1 million in 2026.
- Business Quant data shows SRRK's Restructuring Costs at $16.1 million in Q1 2026, $12.8 million in Q4 2025, and $19.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.60 Mn |
| Mar 31, 2026 | 16.13 Mn |
| Dec 31, 2025 | 12.76 Mn |
| Sep 30, 2025 | 19.43 Mn |
| Jun 30, 2025 | 14.95 Mn |
| Mar 31, 2025 | 8.94 Mn |
| Dec 31, 2024 | 6.16 Mn |
| Sep 30, 2024 | 5.09 Mn |
| Jun 30, 2024 | 6.13 Mn |
| Mar 31, 2024 | 5.00 Mn |